At present, Xenomouse plays a key role in discovery of therapeutic antibodies. Therapeutic antibodies has displaced all other molecules in the race of drug discovery. In small molecules, Hetrocyclic molecules and natural products played a major role. Recently MAbs has taken pivotal role in drug discovery. Discovering and bring to market is always cumbersome process. Especially in MAbs it is complicated. Xenomouse has solved lot of problems. If a known target is there, discovering a novel therapeutic human monoclonal antibodies will take less than a year and validating is simple. From discovery to manufacturing takes around five years. Hence with in a span of six years , you can role out a novel MAb. Statistics says the same.
But acquiring Xenomouse technology is not easy right now. Other than that , getting approval from animal ethics committee is also a trouble. If these two are solved, then from developing countries you can see lot of novel molecules. Read the following report for details of Xenomouse technology
regards
SK
But acquiring Xenomouse technology is not easy right now. Other than that , getting approval from animal ethics committee is also a trouble. If these two are solved, then from developing countries you can see lot of novel molecules. Read the following report for details of Xenomouse technology
regards
SK
| iel1209.pdf |
RSS Feed
